Global Over-The-Counter Drug Markets - Market Research, Industry Trends, Market Share


Published: 01/23/2018
Pages: 171
Full Study Price: US$ 3,995

The report includes discussions of conditions often treated with OTC medicines, health statistics related to the industry, global populations, aging populations, populations by region and issues affecting the market as a whole. Information is presented as a global overview, with special emphasis on primary markets such as the United States, Japan, China, Germany, and other key markets. The market segments provide an overview of demographics, market estimates and market forecasts.

Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. By definition, the FDA has found them to be safe for use without medical supervision. As the pharmaceutical industry has grown, patients have become more involved in health-care issues and now have taken some medical treatment into their own hands. This has provided an opportunity for pharmaceutical companies to invest in research and development of OTC drugs. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • Background
    • Scope and Methodology
    • Size and Growth of the Global OTC Market
      • Table Figure 1-1: Global Over-the-Counter Drug Market Analysis: 2017 to 2023 (millions USD)
      • Global Markets
        • Table Figure 1-2: Top Twenty OTC Drug Markets, Country Market Share (%), 2017
      • Leading Competitors
  • Introduction
    • Background
    • Distribution and Safety Issues in the United States
    • Consumer Advertising and Promotion
    • Global Health
      • Global Life Expectancy
        • Table Average Life Expectancy in Years by Country, 2017 and Projected 2025
        • Table Figure 2-1: Average Life Expectancy in Years by Country, 2017 and Projected 2025
      • Global Trends in Birth Rates
        • Table Crude Birth Rate per 1,000 Persons by Country, 2017 and Projected 2025
        • Table Figure 2-2: Crude Birth Rate per 1,000 Persons by Country, 2017 and Projected 2025
      • Tobacco Use
        • Table Figure 2-3: Percent of Tobacco Users as a Percentage of Population by Country, 1990 vs. 2010 (%)
      • Obesity
        • Table Figure 2-4: Obesity Prevalence as a Percentage of Population by Country, 2006 vs. 2016 (%)
      • Declining Growth of the Global Population
        • Table Global Population 1980 to 2050 (millions)
        • Table Figure 2-5: The Global Population, 1980-2050
        • Table Figure 2-6: Global Population Trends, Total Population vs. Age 65+ Population, 2000-2050
    • Prescription vs. Over-the-Counter Industry
      • Table Figure 2-7: Total Pharmaceutical Markets: Prescription vs. Non-Prescription by Country, 2017 (% of total
    • Over-the-Counter Drug Product Segments
      • Table Global OTC Drug Market Analysis, Markets by Product Segment, 2017 to 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 2-8: Global OTC Drug Market Analysis, Markets by Product Segment, 2017 and 2023
    • Rx-to-OTC Switch Industry
      • Table Leading FDA approved Rx-to-OTC switches, 1994-2017
      • Table Figure 2-9: Number of New Rx-to-OTC Switches in the United States, per year 1976-2017
    • Economic Trends
      • Table Figure 2-10: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, 2010 and 2020 Estimated (%)
      • Purchasing Power Trends
        • Table Figure 2-11: Gross National Income by Country 1990-2010 and Estimated 2020
    • Health Insurance Issues and Trends: United States
      • Table Figure 2-12: Number of Insured vs. Uninsured in the United States 2005-2016
      • Table Figure 2-13: Number of Insured Children vs. Uninsured Children in the United States 2005-2016
      • Table Figure 2-14: Number of Insured Children vs. Uninsured Children in the United States 2005-2016
    • Consumer Issues and Trends
      • Access to Professional Medical Services and the Link to Self-Medication
        • Table Figure 2-15: Practicing Physicians per 1,000 Population by Country, 2017
    • Regulatory Solutions to OTC Drug Access
      • Revisions to Pharmaceutical Affairs Law (PAL) in Japan
        • Table Figure 2-16: Typical Pharmacist-Consumer OTC Drug Counseling Session
      • Changes to Australia's OTC Drug Access - Up-scheduling Combination Medicines Containing Codeine
        • Table Figure 2-17: National Classification System of Scheduling Medicines
  • Over The Counter Central Nervous System Agents
    • Market Summary
      • Table Figure 3-1: Global OTC Central Nervous System Agent Market, 2017-2023
    • Market By Drug Segment
      • Table Figure 3-2: Global OTC Central Nervous System Agent Market, Distribution of Sales by Drug Segment 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 3-3: Asia Pacific OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 3-4: Europe OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 3-5: Latin America OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 3-6: Middle East & Africa OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 3-7: North America OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Dermatological Agents
    • Market Summary
      • Table Figure 4-1: Global OTC Dermatological Agent Market, 2017-2023
    • Market by Drug Segment
      • Table Figure 4-2: Global OTC Dermatological Agent Market, Distribution of Sales by Drug Segment 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 4-3: Asia Pacific OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 4-4: Europe OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 4-5: Latin America OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 4-6: Middle East & Africa OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 4-7: North America OTC Dermatological Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Gastrointestinal System Agents
    • Market Summary
      • Table Figure 5-1: Global OTC Gastrointestinal Agent Market, 2017-2023
    • Market by Drug Segment
      • Table Figure 5-2: Global Gastrointestinal OTC Market, Distribution of Sales by Drug Segment 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 5-3: Asia Pacific OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 5-4: Europe OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 5-5: Latin America OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 5-6: Middle East & Africa OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 5-7: North America OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Respiratory System Agents
    • Market Summary
      • Table Figure 6-1: Global OTC Respiratory Agent Market, 2017-2023
    • Market by Drug Segment
      • Table Figure 6-2: Global OTC Respiratory Agent Market, Distribution of Sales by Drug Segment 2017 (%)
      • Table Global OTC Respiratory Agent Market, Sales by Indication, 2017-2023 ($ in millions)
      • Table Figure 6-3: Global OTC Respiratory Agent Market, Distribution of Sales by Indication 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 6-4: Asia Pacific OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 6-5: Europe OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 6-6: Latin America OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 6-7: Middle East & Africa OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 6-8: North America OTC Respiratory Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Agents-Various Therapeutic Classifications
    • Market Summary
      • Table Figure 7-1: Global OTC Other Therapies Market, 2017-2023
    • Markets by Region
      • Asia Pacific
        • Table Figure 7-2: Asia Pacific OTC Other Therapies Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 7-3: Europe OTC Other Therapies Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 7-4: Latin America OTC Other Therapies Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 7-5: Middle East & Africa OTC Other Therapies Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 7-6: North America OTC Other Therapies Market, 2017-2023 ($ millions)
  • OTC Drug Markets in Asia Pacific
    • Regional Overview
      • Table Asia Pacific Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 8-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Asia Pacific Markets
      • Table Figure 8-2: OTC Drug Market in Asia Pacific Region, 2017-2023 (in millions of dollars at the manufacturers' level)
      • Sales for OTC Drug Markets by Country
        • Table Figure 8-3: Asia Pacific OTC Drug Market Value by Country, 2017 and 2023
        • Table Figure 8-4: Asia Pacific OTC Drug Markets by Country, 2017 (%)
        • Table Figure 8-5: OTC Drug Markets in Japan by Therapeutic Class, 2017 (%)
        • Table Figure 8-6: OTC Drug Markets in China by Therapeutic Class, 2017 (%)
        • Table Figure 8-7: OTC Drug Markets in India by Therapeutic Class, 2017 (%)
        • Table Figure 8-8: OTC Drug Markets in Australia by Therapeutic Class, 2017 (%)
    • Asia Pacific OTC Markets by Therapeutic Class
      • Table Asia-Pacific OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 8-9: Asia-Pacific OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in Europe
    • Regional Overview
      • Table Europe Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 9-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Europe Markets
      • Table Figure 9-2: OTC Drug Market in Europe Region, 2017-2023 (in millions of dollars at the manufacturers' level)
    • Sales for OTC Drug Markets by European Country
      • Table Figure 9-3: Europe OTC Drug Market Value by Country, 2017 and 2023
      • Table Figure 9-4: Europe OTC Drug Markets by Country, 2017 (%)
      • Germany
        • Table Figure 9-5: OTC Drug Markets in Germany by Therapeutic Class, 2017 (%)
      • France
        • Table Figure 9-6: OTC Drug Markets in France by Therapeutic Class, 2017 (%)
      • Russia
        • Table Figure 9-7: OTC Drug Markets In Russia by Therapeutic Class, 2017 (%)
      • United Kingdom
        • Table Figure 9-8: OTC Drug Markets in The United Kingdom by Therapeutic Class, 2017 (%)
      • Italy
        • Table Figure 9-9: OTC Drug Markets in Italy by Therapeutic Class, 2017 (%)
      • Spain
        • Table Figure 9-10: OTC Drug Markets in Spain by Therapeutic Class, 2017 (%)
      • Poland
        • Table Figure 9-11: OTC Drug Markets in Poland by Therapeutic Class, 2017 (%)
      • Turkey
        • Table Figure 9-12: OTC Drug Markets in Turkey by Therapeutic Class, 2017 (%)
    • Europe OTC Markets by Therapeutic Class
      • Table Europe OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 9-13: Europe OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in Latin America
    • Regional Overview
      • Table Latin America Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 10-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Latin America Markets
      • Table OTC Drug Market in Latin America Region, 2017-2023 (in millions of dollars at the manufacturers' level)
    • Sales for OTC Drug Markets by Country
      • Table Figure 10-2: Latin America OTC Drug Market Value by Country, 2017 and 2023
      • Table Figure 10-3: Latin America OTC Drug Markets by Country, 2017 (%)
      • Brazil
        • Table Figure 10-4: OTC Drug Markets in Brazil by Therapeutic Class, 2017 (%)
      • Mexico
        • Table Figure 10-5: OTC Drug Markets in Mexico by Therapeutic Class, 2017 (%)
      • Argentina
        • Table Figure 10-6: OTC Drug Markets in Argentina by Therapeutic Class, 2017 (%)
      • Venezuela
        • Table Figure 10-7: OTC Drug Markets in Venezuela by Therapeutic Class, 2017 (%)
    • Latin America OTC Markets by Therapeutic Class
      • Table Latin America OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 10-8: Latin America OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in Middle East & Africa
    • Regional Overview
      • Table Middle East & Africa Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 11-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Middle East & Africa Markets
      • Table Figure 11-2: OTC Drug Market in Middle East & Africa Region, 2017-2023 (in millions of dollars at the manufacturers' level)
    • Sales for OTC Drug Markets by Country
      • Table Figure 11-3: Middle East & Africa OTC Drug Market Value by Country, 2017 and 2023
      • Table Figure 11-4: OTC Drug Markets by Country, 2017 (%)
      • South Africa
        • Table Figure 11-5: OTC Drug Markets in South Africa by Therapeutic Class, 2017 (%)
      • Saudi Arabia
        • Table Figure 11-6: OTC Drug Markets in Saudi Arabia by Therapeutic Class, 2017 (%)
    • Middle East & Africa OTC Markets by Therapeutic Class
      • Table Middle East & Africa OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 11-7: Middle East & Africa OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in North America
    • Regional Overview
      • Table North America Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 12-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in North America Markets
      • Table Figure 12-2: OTC Drug Markets in North America Region, 2017-2023 (in millions of dollars at the manufacturers' level)
      • Sales for OTC Drug Markets by Country
        • Table Figure 12-3: North America OTC Drug Market Value by Country, 2017 and 2023
        • Table Figure 12-4: North America OTC Drug Markets by Country, 2017 (%)
      • United States
        • Table Figure 12-5: OTC Drug Markets in the United States by Therapeutic Class, 2017 (%)
      • Canada
        • Table Figure 12-6: OTC Drug Markets in Canada by Therapeutic Class, 2017 (%)
    • North America OTC Markets by Therapeutic Class
      • Table North America OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 12-7: North America OTC Drug Market by Therapeutic Class, 2017 and 2023
  • Leading OTC Drug Manufacturers
    • Overview
    • Competitor Analysis
      • GlaxoSmithKline Grabs Top Market Position
      • Bayer Holds Second in a Highly Competitive Market
      • Sanofi Climbs to Third in Market with Recent Acquisition
      • Johnson & Johnson Maintains a Top Market Position in OTC Drugs despite Growing Consolidation and Competition
      • Reckitt Benckiser Maintains Consistent Sales
      • Perrigo Is the Leading Off-Brand OTC Drug Company
      • Pfizer Is Steadfast
      • Taisho Pharmaceutical: Japan's Leading OTC Drug Supplier
      • Procter & Gamble Shows Slow, Steady Growth
        • Table Leading Suppliers Shares of the OTC Drug Market by Revenues-2017
        • Table Figure 13-1: Leading Suppliers Shares of the OTC Drug Market, 2017
    • A Decade of Agreements, Mergers and Acquisitions Shaping the OTC Drug Market
      • Sanofi and Boehringer Ingelheim
      • GlaxoSmithKline and Novartis AG
      • Bayer AG and Merck & Co.
      • Prestige Brands and Insight Pharmaceuticals
      • Perrigo Company Acquisitions
      • Procter & Gamble and Teva Pharmaceutical Industries
      • Sanofi and Chattem Consumer
      • Wyeth and Pfizer
      • Reckitt Benckiser and Adams Respiratory Therapeutics
    • Leading Corporate Profiles
      • Bayer AG
        • Table Bayer Corporate Summary
        • Table Bayer Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • GlaxoSmithKline plc
        • Table GlaxoSmithKline Corporate Summary
        • Table GlaxoSmithKline Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Johnson & Johnson
        • Table Johnson & Johnson Corporate Summary
        • Table Johnson & Johnson Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Mylan N.V.
        • Table Mylan Corporate Summary
        • Table Mylan Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Perrigo Company plc
        • Table Perrigo Company Corporate Summary
        • Table Perrigo Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Pfizer, Inc.
        • Table Pfizer Corporate Summary
        • Table Pfizer Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Procter & Gamble Company
        • Table Procter & Gamble Company Corporate Summary
        • Table Procter & Gamble Recent Revenue History, 2015-2017 (US$ Millions, financial year ending June)
      • Reckitt Benckiser Group Plc
        • Table Reckitt Benckiser Group Corporate Summary
        • Table Reckitt Benckiser Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Sanofi
        • Table Sanofi Corporate Summary
        • Table Sanofi Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Taisho Pharmaceutical Holding Co., Ltd.
        • Table Taisho Pharmaceutical Holding Corporate Summary
        • Table Taisho Pharmaceutical Recent Revenue History, FY End 2016-2017 (US$ Millions, financial year ending March)